"Study Suggests Ozempic Can Be Made for Less Than $5 a Month, Prompting Calls for Price Reduction"
TL;DR Summary
A study by researchers at Yale University, King’s College Hospital, and Doctors Without Borders suggests that Ozempic, a diabetes drug manufactured by Novo Nordisk, could be produced for as little as 89 cents to $4.73 per month, including a profit margin, despite being sold for $968.52 per month in the US. This raises concerns about the pricing of diabetes and obesity treatments.
- Ozempic, Novo's $1000 Diabetes Shot, Can Be Made for Under $5 a Month Bloomberg
- Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests CNBC
- Bernie Sanders Calls On Novo Nordisk To Lower Cost Of Ozempic And Wegovy Forbes
- Ozempic, Novo’s $1,000 Diabetes Drug, Can Be Made for Less Than $5 a Month, Study Says Forex Factory
- Sanders calls for Novo Nordisk to slash Ozempic, Wegovy prices The Hill
Reading Insights
Total Reads
0
Unique Readers
11
Time Saved
0 min
vs 1 min read
Condensed
35%
96 → 62 words
Want the full story? Read the original article
Read on Bloomberg